InsiderTrades

Form 4 for ENTA ENANTA PHARMACEUTICALS INC

Accepted 2021-10-13 00:00:00 ET · period of report 2021-10-08 · accession 0001177648-21-000027 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2021-10-13 2021-10-08+ ENTA Adda Nathalie SVP, Chief Medical Off M - OptEx $43.46 +17.5K 31.0K +130% +$760.5K
DM 2021-10-13 2021-10-08+ ENTA Adda Nathalie SVP, Chief Medical Off S - Sale+OE $70.15 -17.5K 26.9K -39% -$1.23M
DM 2021-10-13 2021-10-08+ ENTA Adda Nathalie SVP, Chief Medical Off M - OptEx $0.00 -17.5K 58.8K -23% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-10-08 M A 13,453 $43.46 40,397 D — —
2 Common Common Stock 2021-10-11 S D 4,047 $70.34 26,944 D — — (F3) The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $70.05 to $70.85, inclusive.
3 Common Common Stock 2021-10-11 M A 4,047 $43.46 30,991 D — —
4 Common Common Stock 2021-10-08 S D 13,453 $70.09 26,944 D — — (F2) The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $70.00 to $70.30, inclusive.
5 Derivative Stock Option (Right to Buy) 2021-10-11 M D 4,047 $0.00 54,770 D $43.46 · — to 2025-06-29 4,047 Common Stock (F4) 100% of the shares subject to the option are fully vested and exercisable.
6 Derivative Stock Option (Right to Buy) 2021-10-08 M D 13,453 $0.00 58,817 D $43.46 · — to 2025-06-29 13,453 Common Stock (F4) 100% of the shares subject to the option are fully vested and exercisable.